- Home
- MEGL vs BFRI Comparison
MEGL vs BFRI Comparison
Compare MEGL & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEGL
- BFRI
- Stock Information
- Founded
- MEGL 2016
- BFRI 1997
- Country
- MEGL Hong Kong
- BFRI United States
- Employees
- MEGL N/A
- BFRI N/A
- Industry
- MEGL Finance: Consumer Services
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- MEGL Finance
- BFRI Health Care
- Exchange
- MEGL Nasdaq
- BFRI Nasdaq
- Market Cap
- MEGL 6.8M
- BFRI 7.9M
- IPO Year
- MEGL 2022
- BFRI 2021
- Fundamental
- Price
- MEGL $1.64
- BFRI $0.87
- Analyst Decision
- MEGL
- BFRI Strong Buy
- Analyst Count
- MEGL 0
- BFRI 1
- Target Price
- MEGL N/A
- BFRI $2.75
- AVG Volume (30 Days)
- MEGL 111.6K
- BFRI 377.7K
- Earning Date
- MEGL 10-29-2025
- BFRI 11-12-2025
- Dividend Yield
- MEGL N/A
- BFRI N/A
- EPS Growth
- MEGL N/A
- BFRI N/A
- EPS
- MEGL N/A
- BFRI N/A
- Revenue
- MEGL $1,645,862.00
- BFRI $39,188,000.00
- Revenue This Year
- MEGL N/A
- BFRI $11.07
- Revenue Next Year
- MEGL N/A
- BFRI $11.20
- P/E Ratio
- MEGL N/A
- BFRI N/A
- Revenue Growth
- MEGL N/A
- BFRI 11.20
- 52 Week Low
- MEGL $1.02
- BFRI $0.54
- 52 Week High
- MEGL $5.52
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- MEGL 53.96
- BFRI 49.45
- Support Level
- MEGL N/A
- BFRI $0.81
- Resistance Level
- MEGL $1.80
- BFRI $0.86
- Average True Range (ATR)
- MEGL 0.12
- BFRI 0.05
- MACD
- MEGL -0.03
- BFRI -0.00
- Stochastic Oscillator
- MEGL 91.11
- BFRI 47.20
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.